Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes

BACKGROUND: COVID-19 continues to inflict significant morbidity and mortality, particularly on patients with preexisting health conditions. The clinical course, outcomes, and significance of immunosuppression regimen in heart transplant recipients with COVID-19 remains unclear. METHODS: We included...

Descripción completa

Detalles Bibliográficos
Autores principales: Genuardi, Michael V., Moss, Noah, Najjar, Samer S., Houston, Brian A., Shore, Supriya, Vorovich, Esther, Atluri, Pavan, Molina, Maria, Chambers, Susan, Sharkoski, Tiffany, Hsich, Eileen, Estep, Jerry D., Owens, Anjali T., Alexander, Kevin M., Chaudhry, Sunit-Preet, Garcia-Cortes, Rafael, Molina, Ezequiel, Rodrigo, Maria, Wald, MDc Joyce, Margulies, Kenneth B., Hanff, Thomas C., Zimmer, Ross, Kilic, Arman, Mclean, Rhondalyn, Vidula, Himabindu, Dodd, Katherine, Blumberg, Emily A., Mazurek, Jeremy A., Goldberg, Lee R., Alvarez-Garcia, Jesus, Mancini, Donna, Teuteberg, Jeffrey J., Tedford, Ryan J., Birati, Edo Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2021
Materias:
Original Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131557/
https://www.ncbi.nlm.nih.gov/pubmed/34140222
http://dx.doi.org/10.1016/j.healun.2021.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131557/
https://www.ncbi.nlm.nih.gov/pubmed/34140222
http://dx.doi.org/10.1016/j.healun.2021.05.006

Ejemplares similares